Pharmafile Logo

Making at Impact at the Alliance Industry Summit

- PMLiVE

The Medscape team will be returning to the Alliance Industry Summit in Philadelphia this year, bringing with them Best in Class Outcomes and support for the event. As part of their dedication to and leadership in the continuing education in the health professions community, Medscape is proud to act as a silver sponsor of the AIS event.

“We look forward to the Alliance Industry Summit every year, and we’re pleased to be a silver sponsor for 2024. The conference is a great opportunity to connect with our education colleagues from across the country to share best practices and collaborate on ways to move the industry forward,” said Laura Gaskell, Senior Marketing Director. “We’re particularly excited to be bringing with us a poster for the Best in Class Outcomes reception. Our programs have produced valuable real-world outcomes and insights that prove the power of education, and we’re looking forward to sharing them.”

Medscape’s poster, “Real-World Outcomes in Alzheimer’s Disease,” will be available during the Best in Class reception on Monday, September 16, from 5:30-6:30PM. Katie Lucero, PhD, Chief Impact Officer, will be available during the session to discuss the poster and Medscape’s education impact.

For more information on Medscape’s activities during AIS, please contact Laura Gaskell at LGaskell@Medscape.net.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Contagious Conversations: Exploring Infectious Disease in the Digital Age

As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...

Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens

From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...

Impacting Lives with Rare Disease Education

Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...

Medscape’s Virtual Patient Simulation Makes a Significant Impact on Real-World Treatment Selection for T2D

An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,...

A Rare Disease Update from Medscape Education

A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency

New Outcomes Are a Breath of Fresh Air at ERS

ERS 2023 will mark the new release of outcomes data by Medscape Education Global. During the poster hall sessions on September 12, the Medscape team will present a poster that...

Medscape Education Launches 20th Older Driver Safety Educational Program

Education Supported by the National Highway Traffic Safety Administration

Protecting the Heart Through Education at ESC 2023

Medscape Education Global is joining cardiology professionals from across Europe for ESC 2023 in Amsterdam. This year’s congress theme is “Joining Forces to Protect the Heart,” and Medscape will be...

Medscape’s Rare Disease Learning Center Has Reached 1 Million Learners

The Pathways in Rare Disease Learning Center celebrates a momentous achievement - engaging one million learners in its educational initiatives. This milestone signifies a profound impact on clinician confidence in...

Continuing Medical Education Outcomes are Much More Than Statistical Significance

At Medscape Education, we hold ourselves to the highest standards when it comes to analysing our programs. Our approach is unparalleled, employing a precise paired method that ensures we measure the...